(2022). Letter: A promising Helicobacter pylori regimen—vonoprazan‐based therapy. Author's reply. Alimentary Pharmacology & Therapeutics, 56(4), 754. https://doi.org/10.1111/apt.17133
Chicago Style (17th ed.) Citation"Letter: A Promising Helicobacter Pylori Regimen—vonoprazan‐based Therapy. Author's Reply." Alimentary Pharmacology & Therapeutics 56, no. 4 (2022): 754. https://doi.org/10.1111/apt.17133.
MLA (9th ed.) Citation"Letter: A Promising Helicobacter Pylori Regimen—vonoprazan‐based Therapy. Author's Reply." Alimentary Pharmacology & Therapeutics, vol. 56, no. 4, 2022, p. 754, https://doi.org/10.1111/apt.17133.
Warning: These citations may not always be 100% accurate.
